Potential New Therapeutic Targets for Cystic Fibrosis Identified

by VR Sreeraman on  February 15, 2010 at 6:27 PM Research News
RSS Email Print This Page Comment bookmark
Font : A-A+

 Potential New Therapeutic Targets for Cystic Fibrosis Identified
Scientists from the University of California, San Diego School of Medicine, have identified potential targets for treatment of patients with cystic fibrosis.

They have discovered a defective signaling pathway that contributes to disease severity.

In the study, researchers found that defective signaling for a protein called the peroxisome proliferator-activated receptor-? (PPAR-?) accounts for a portion of disease symptoms in cystic fibrosis, and that correction of the defective pathway reduces symptoms of the disease in mice.

Lead author Gregory Harmon, study supervisor Christopher Glass, and colleagues showed that both mice and cells from patients with cystic fibrosis have a defect in signaling for PPAR-?, as a result of reduced levels of prostaglandins that activate the receptor.

Cystic fibrosis is a multisystem condition that leads to progressive lung failure, pancreatic failure and gastrointestinal obstruction, or blockage.

The study has been published in the journal Nature Medicine.

Source: ANI
SRM

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Genetic Testing of Diseases Cystic Fibrosis Fibroscan for Fatty Liver Cirrhosis and Fibrosis Retroperitoneal Fibrosis / Ormondīs Disease 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...